|
Market Closed -
Nasdaq
21:00:00 16/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 40.61 USD | +0.79% |
|
+1.35% | -16.20% |
| 12:37pm | RBC Cuts Price Target on Sanofi to EUR75 From EUR80, Keeps Sector Perform Rating | MT |
| 07:41am | Sanofi : Gets a Neutral rating from RBC | ZD |
Company Valuation: Sanofi
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 111,194 | 112,665 | 112,549 | 116,968 | 100,655 | 86,189 | - | - |
| Change | - | 1.32% | -0.1% | 3.93% | -13.95% | -14.37% | - | - |
| Enterprise Value (EV) 1 | 121,177 | 119,102 | 120,342 | 125,740 | 111,663 | 97,526 | 94,194 | 91,528 |
| Change | - | -1.71% | 1.04% | 4.49% | -11.2% | -12.66% | -3.42% | -2.83% |
| P/E | 17.8x | 16.7x | 20.8x | 20.4x | 12.9x | 11.7x | 10.3x | 8.82x |
| PBR | 1.62x | 1.5x | 1.52x | 1.51x | 1.41x | 1.17x | 1.1x | 1.04x |
| PEG | - | 2.07x | -1.1x | 3.14x | 0.3x | -3.04x | 0.7x | 0.5x |
| Capitalization / Revenue | 2.94x | 2.62x | 2.61x | 2.85x | 2.31x | 1.82x | 1.71x | 1.62x |
| EV / Revenue | 3.21x | 2.77x | 2.79x | 3.06x | 2.56x | 2.06x | 1.87x | 1.72x |
| EV / EBITDA | 9.95x | 8.14x | 8.44x | 9.76x | 8.22x | 6.59x | 5.97x | 5.34x |
| EV / EBIT | 11.3x | 9.13x | 9.5x | 11.1x | 9.19x | 7.43x | 6.85x | 6.14x |
| EV / FCF | 15x | 14x | 14.2x | 21.1x | 13.8x | 11.9x | 10.5x | 9.13x |
| FCF Yield | 6.68% | 7.12% | 7.04% | 4.74% | 7.24% | 8.44% | 9.54% | 11% |
| Dividend per Share 2 | 3.33 | 3.56 | 3.76 | 3.92 | 4.12 | 4.256 | 4.502 | 4.801 |
| Rate of return | 3.76% | 3.96% | 4.19% | 4.18% | 4.98% | 5.9% | 6.24% | 6.65% |
| EPS 2 | 4.97 | 5.37 | 4.31 | 4.59 | 6.4 | 6.154 | 7.036 | 8.181 |
| Distribution rate | 67% | 66.3% | 87.2% | 85.4% | 64.4% | 69.2% | 64% | 58.7% |
| Net sales 1 | 37,761 | 42,997 | 43,070 | 41,081 | 43,626 | 47,398 | 50,486 | 53,250 |
| EBITDA 1 | 12,183 | 14,627 | 14,259 | 12,889 | 13,583 | 14,808 | 15,785 | 17,152 |
| EBIT 1 | 10,714 | 13,040 | 12,670 | 11,343 | 12,149 | 13,123 | 13,761 | 14,897 |
| Net income 1 | 6,223 | 6,720 | 5,400 | 5,744 | 7,813 | 7,460 | 8,718 | 10,168 |
| Net Debt 1 | 9,983 | 6,437 | 7,793 | 8,772 | 11,008 | 11,337 | 8,005 | 5,339 |
| Reference price 2 | 88.58 | 89.84 | 89.76 | 93.74 | 82.72 | 72.16 | 72.16 | 72.16 |
| Nbr of stocks (in thousands) | 1,255,293 | 1,254,060 | 1,253,891 | 1,247,793 | 1,216,810 | 1,198,069 | - | - |
| Announcement Date | 04/02/22 | 03/02/23 | 01/02/24 | 30/01/25 | 29/01/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 35.8x | 12.9x | 27.02x | 0.55% | 1,116B | |
| 37.07x | 6.25x | 17.38x | 2.11% | 610B | |
| 36.17x | 8.31x | 17.13x | 2.45% | 501B | |
| 112.15x | 5.92x | 25.35x | 2.35% | 358B | |
| 20.49x | 5x | 12.4x | 2.64% | 366B | |
| 21.24x | 5.55x | 13.66x | 2.88% | 288B | |
| 22x | 4.43x | 12.71x | 1.99% | 261B | |
| 27.56x | 7.08x | 12.68x | 2.32% | 235B | |
| -45.98x | 7.04x | 27.26x | 2.1% | 195B | |
| Average | 29.61x | 6.94x | 18.40x | 2.15% | 436.64B | |
| Weighted average by Cap. | 35.04x | 8.17x | 19.98x | 1.84% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- SAN Stock
- SNY Stock
- Valuation Sanofi
Select your edition
All financial news and data tailored to specific country editions
